Esteban Santos - Amgen Insider

Amgen Inc -- USA Stock  

USD 170.12  0.16  0.0941%

Executive Vice President Operations

Mr. Esteban Santos is Executive Vice President, Operations of the Company. Mr. Santos became Executive Vice President, Operations in July 2016. Mr. Santos joined the Company in 2007 as Executive Director, Manufacturing Technologies. From October 2008 to May 2013, Mr. Santos held a number of Vice President roles at the Company in engineering, manufacturing, site operations and drug product. From May 2013 to July 2016, Mr. Santos was Senior Vice President, Manufacturing. Prior to joining the Company, Mr. Santos served as Site General Manager for JJs Cordis operation in Puerto Rico. Prior to JJ, Mr. Santos held several management positions in GEs industrial and transportation businesses.
Age: 48  President Since 2016      
805 447-1010

Esteban Santos Latest Insider Activity

Esteban Santos over three months ago via Macroaxis 
Amgen exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Paul SilvaVertex Pharmaceuticals Incorpor
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
Robert FunckAbbott Laboratories
Ian SmithVertex Pharmaceuticals Incorpor
Michael PariniVertex Pharmaceuticals Incorpor
Jonathon KellermanAllergan plc
Amit SachdevVertex Pharmaceuticals Incorpor
Philippe SchaisonAllergan plc
Thomas GraneyVertex Pharmaceuticals Incorpor
Daniel SalvadoriAbbott Laboratories
Paul NavarreAllergan plc
Shawn SoderbergBio Rad Laboratories Inc
Jared WatkinAbbott Laboratories
Deepak NathAbbott Laboratories
Robert FordAbbott Laboratories
Michael CrowleyBio Rad Laboratories Inc
Brian LortieEndo International plc
Matthew MalettaEndo International plc
Michael WarmuthAbbott Laboratories
Ronald HuttonBio Rad Laboratories Inc
William MeuryAllergan plc

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators